rs12241932 - MPP7
Magnitude 2.2 · 3 studies on file
Reported associations
-
Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis - Unknown journal (n.d.) · Unknown authors · PubMed 28869591
ABSTRACT: Osteoporosis is a common disease diagnosed primarily by measurement of bone mineral density (BMD). We undertook a genome-wide association study in 142,487 individuals from the UK Biobank to identify loci associated with BMD estimated by quantitative ultrasound of the heel ("eBMD"). We identified 307 conditionally independent SNPs attaining genome-wide significance at 203 loci, explaining approximately 12% of the phenotypic variance. These included 153 novel loci, and several rare variants with large effect sizes. To investigate underlying mechanisms we undertook: 1) bioinformatic, functional genomic annotation and human osteoblast expression studies; 2) gene function prediction; 3) skeletal phenotyping of 120 knockout mice with deletions of genes adjacent to lead independent
-
A saturated map of common genetic variants associated with human height - Unknown journal (n.d.) · Unknown authors · PubMed 36224396
ABSTRACT: Common single-nucleotide polymorphisms (SNPs) are predicted to collectively explain 40-50% of phenotypic variation in human height, but identifying the specific variants and associated regions requires huge sample sizes. Here, using data from a genome-wide association study of 5.4 million individuals of diverse ancestries, we show that 12,111 independent SNPs that are significantly associated with height account for nearly all of the common SNP-based heritability. These SNPs are clustered within 7,209 non-overlapping genomic segments with a mean size of around 90 kb, covering about 21% of the genome. The density of independent associations varies across the genome and the regions of increased density are enriched for biologically relevant genes. In out-of-sample estimation
-
Identification of 613 new loci associated with heel bone mineral density and a polygenic risk score for bone mineral density, osteoporosis and fracture - Unknown journal (n.d.) · Unknown authors · PubMed 30048462
ABSTRACT: Low bone mineral density (BMD) leads to osteoporosis, and is a risk factor for bone fractures, including stress fractures. Using data from UK Biobank, a genome-wide association study identified 1,362 independent SNPs that clustered into 899 loci of which 613 are new. These data were used to train a genetic algorithm using 22,886 SNPs as predictors and showing a correlation with heel bone mineral density of 0.415. Combining this genetic algorithm with height, weight, age and sex resulted in a correlation with heel bone mineral density of 0.496. Individuals with low scores (2.2% of total) showed a change in BMD of -1.16 T-score units, an increase in risk for osteoporosis of 17.4 fold and an increase in risk for fracture of 1.87 fold. Genetic predictors could assist in the identific
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Diet
-
adequate calcium intake High
Genetic predisposition to low BMD increases osteoporosis risk; adequate calcium is essential for bone mineralization.
1000-1200 mg calcium daily through food (dairy, leafy greens, fortified foods)
-
adequate vitamin D intake High
Vitamin D is necessary for calcium absorption and bone formation, critical for genetic predisposition to low BMD.
Target 25-hydroxyvitamin D level of 30-50 ng/mL through sun exposure, food, or supplementation
Exercise
-
weight-bearing and resistance exercise High
Genetic predisposition to lower BMD increases fracture risk; weight-bearing exercise is an evidence-based intervention.
30 minutes of weight-bearing or resistance exercise, 3-4 times weekly
Screening
-
bone mineral density via DEXA scan High
Genetic variant associated with reduced heel bone mineral density; early screening identifies fracture risk.
Baseline DEXA scan at age 30-35 for females, 40-45 for males; repeat every 2-5 years if normal
Supplements
-
calcium and vitamin D supplements Moderate
Supplementation ensures adequate micronutrient intake when dietary sources are insufficient to support bone health.
Supplement if dietary intake insufficient; 500-1000 mg calcium and 1000-2000 IU vitamin D daily as needed